Which is more profitable, Roche or UCB SA?

Roche keeps more of every sale as profit.

Which grows faster, Roche or UCB SA?

UCB SA grew its sales faster in recent years.

Which is cheaper, Roche or UCB SA?

Roche costs less for each unit of yearly profit (lower P/E).

Which has less debt, Roche or UCB SA?

UCB SA would need fewer years of earnings to pay off its debt.

RocheRO.SWvs

UCB SAUCB.BR

Roche vs UCB SA stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

Roche is more profitable and is cheaper for its profits. UCB SA grows faster and has less debt.

Side by side

	Roche	UCB SA
	CHF 328 billion	€56.5 billion
	20.3%	20.1%
	−1.3%	+12.0%
	25.5×	36.3×
	1.3 years	Net cash
	23.2%	11.2%
	2.4%	0.5%

Open Roche Open UCB SA

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: Roche vs UnitedHealth · Roche vs Vertex Pharmaceuticals · Roche vs AbbVie · Roche vs Abbott Laboratories · UCB SA vs UnitedHealth · UCB SA vs AbbVie · UCB SA vs Johnson & Johnson · UCB SA vs Eli Lilly